Dow +0.18 %
22381pts, Nasdaq+0.00 % a 6453pts , S&P+ 0.12% 2510pts

| $ZYNE |
|
|
|
|
|
|
| Zynerba
Pharmaceuticals Inc |
|
|
|
|
|
| Industria:Farmacéutica |
|
|
|
|
|
| Sector:
Healthcare |
|
|
|
|
|
|
|
|
|
|
|
|
$ZYNE subio 52.67% a $9.45 luego de anunciar un psoitivo estudio sobre cannabis
medicinal


| $DXCM |
|
|
|
|
|
|
| DexCom |
|
|
|
|
|
|
| Industria:
Laboratorios Mèdicos |
|
|
|
|
| Sector:
Healthcare |
|
|
|
|
|
|
|
|
|
|
|
|
| $DXCM bajo 32.78 % a $45.35 luego de que la FDA aprobara plicación de glucosa para Abbot
competencia |
directa de
$DXCM
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Otros Stocks: |
|
|
|
|
|
| $ZYNE
, $EXA , $BYBK , $AMMA , $ITUS , $PME , $HIIQ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No hay comentarios:
Publicar un comentario